Throughout the last three months, 5 analysts have evaluated IDEXX Laboratories (NASDAQ:IDXX), offering a diverse set of opinions from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 0 | 2 | 3 | 0 | 0 |
| Last 30D | 0 | 1 | 1 | 0 | 0 |
| 1M Ago | 0 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 0 | 0 | 0 | 0 |
| 3M Ago | 0 | 0 | 1 | 0 | 0 |
Insights from analysts' 12-month price targets are revealed, presenting an average target of $502.2, a high estimate of $575.00, and a low estimate of $435.00. This current average has decreased by 11.27% from the previous average price target of $566.00.
Interpreting Analyst Ratings: A Closer Look
The standing of IDEXX Laboratories among financial experts is revealed through...
Login or create a forever free account to read this news
Sign up/Log in
